Journals / Turkish journal of nephrology (Online) / 2020 / Cilt: 29 - Sayı: 1

Why Crossmatch Tests are Very Important and What Do They Tell Us?

Pages
77–81
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Crossmatch tests are routinely used prior to transplantation to prevent acute humoral reactions to the allograft tissue following reperfusion and also for long-term monitoring of the patient’s humoral status during the pre- and post-transplantation periods.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Organ transplantation is a very complex procedure that can save lives.
📊
Key Findings & Data:It is a very useful procedure if the concepts of immunology, gained through bitter experience over the years, are kept in mind during practice.
💡
Conclusion & Impact:Crossmatch tests are routinely used prior to transplantation to prevent acute humoral reactions to the allograft tissue following reperfusion and also for long-term monitoring of the patient’s humoral status during the pre- and post-transplantation periods.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Organ transplantation is a very complex procedure that can save lives. It is a very useful procedure if the concepts of immunology, gained through bitter experience over the years, are kept in mind during practice. Allogeneic sensitization due to previous exposure(s) to alloantigens can hamper the procedure and remains the main obstacle to organ transplantation. Allosensitization and its level in a patient can be revealed before transplantation using the crossmatch test performed by incubating the patient’s serum with the possible donor’s lymphocytes in a laboratory environment. Crossmatch tests are routinely used prior to transplantation to prevent acute humoral reactions to the allograft tissue following reperfusion and also for long-term monitoring of the patient’s humoral status during the pre- and post-transplantation periods.

🔖

Cite This Article

TİTİZ, M. İ., BİLGEN, T. (2020). Why Crossmatch Tests are Very Important and What Do They Tell Us?. Turkish journal of nephrology (Online), Cilt: 29 - Sayı: 1, 77–81. https://ajindex.com/articles/374855

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Vaughan R, Shaw O. How much donor human leukocyte antigen-specific antibody is too much for a renal transplant? Transplantation 2008
  2. [CrossRef] 2. Schinstock CA, Gandhi MJ, Stegall MD. Interpreting anti-hla antibody testing data: a practical guide for physicians. Transplantation 2016
  3. [CrossRef] 3. Schlaf G, Apel S, Wahle A, Altermann WW. Solid phase-based cross-matching as solution for kidney allograft recipients pretreated with therapeutic antibodies. Biomed Res Int 2015
  4. 587158. [CrossRef] 4. Gautreaux M, D. Histocompatibility Testing in the Transplant Setting in Kidney Transplantation, Bioengineering and Regeneration. 1st ed. Academic Press 2017. [CrossRef] 5. Ata P. Bağışıklık Sistemi ve Antikorlar. Titiz MI, editor. Laboratuvardan Kliniğe Transplantasyon Pratiği. 1st ed. Tekirdağ 2017. 6. Hönger G, Hopfer H, Arnold ML, Spriewald BM, Schaub S, Amico P. Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection. Transplantation 2011
  5. [CrossRef] 7. Ata P, Canbakan M, Kara M, Özel L, Ünal E, Titiz M. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization. Transplant Proc 2012
  6. [CrossRef] 8. Bilgen T, Ata P, Tozkir J, Tozkir H, Titiz MI. Cytotoxic Antibody detection by means of flow-cytometric cross-match. Transplant Proc 2017
  7. [CrossRef] 9. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003
  8. [CrossRef] 10. Requião-Moura LR, Durão MeS, Tonato EJ, Matos AC, Ozaki KS, Câmara NO, et al. Effects of ischemia and reperfusion injury on longterm graft function. Transplant Proc 2011
  9. [CrossRef] 11. Kosieradzki M, Rowiński W. Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. Transplant Proc 2008
  10. [CrossRef] 12. Terasaki PI, Cai J. Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation 2008
  11. [CrossRef] 13. Terasaki PI. A personal perspective: 100-year history of the humoral theory of transplantation. Transplantation 2012
  12. [CrossRef] 14. Platt JL, Cascalho M. B Cells in transplantation of rat, mouse, and man. Transplantation 2018
  13. [CrossRef] 15. Piazza A, Ozzella G, Poggi E, Caputo D, Manfreda A, Adorno D. Virtual crossmatch in kidney transplantation. Transplant